David Mego, MD
Basic profileDavid Mego is a Cardiology physician affiliated with Arkansas Heart Hospital. OpenAlex indexes 34 publications with 506 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20241 payment$179
- Abbott LaboratoriesProgram year20222 payments$173
- Boston Scientific CorporationProgram year20221 payment$83
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.1%Beta blocker24.9%Metoprolol Succinate39%Carvedilol20%Atenolol20%Metoprolol Tartrate12%Bystolic9%Part D<11 patientsAngiotensin receptor blocker (ARB)17%Losartan Potassium69%Olmesartan Medoxomil17%Olmesartan-Hydrochlorothiazide14%Part D<11 patients+ 7 more classes in this area
Blood & clotting
19.3%P2Y12 inhibitor11.8%Clopidogrel100%Part D≥28 patientsFactor Xa inhibitor7.5%Eliquis60%Xarelto40%Part D<11 patientsMetabolism & gastrointestinal
5.6%Potassium supplement5.6%Potassium Chloride100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Balloon-Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: 9-Month Results from the BOLSTER Multicenter Study
Journal of Vascular and Interventional Radiology
2019 - Assessment of Vascular Patency and Inflammation with Intravascular Optical Coherence Tomography in Patients with Superficial Femoral Artery Disease Treated with Zilver PTX Stents
Cardiovascular revascularization medicine
2019 - MitraClip Deployed via Left Femoral Vein in an 85-Year-Old Woman with Mitral Regurgitation
Texas Heart Institute Journal
2019 - CRT-200.08 Paclitaxel-Eluting Stents in the Superficial Femoral Artery at 12-Month Follow-Up Are Associated With Persistent Inflammation
JACC: Cardiovascular Interventions
2019 - Same versus next day discharge after elective transradial PCI: The RAdial SAme Day DischArge after PCI trial. (The RASADDA-PCI trial)
Cardiovascular revascularization medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Scott Beau, MD
Arkansas Heart Hospital
Ian Cawich, MD
Arkansas Heart Hospital
Andre Paixao, MD
Arkansas Heart Hospital
Andrew Hinson, MD
Arkansas Heart Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”